Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1.46M
-
Shares change
-
+655K
-
Total reported value, excl. options
-
$11.1M
-
Value change
-
+$5M
-
Number of buys
-
19
-
Number of sells
-
-9
-
Price
-
$7.60
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q2 2019
30 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q2 2019.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.46M shares
of 127M outstanding shares and own 1.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (555K shares), VANGUARD GROUP INC (323K shares), GEODE CAPITAL MANAGEMENT, LLC (184K shares), Moors & Cabot, Inc. (91.4K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (86.5K shares), NORTHERN TRUST CORP (41.1K shares), Bank of New York Mellon Corp (27.5K shares), NUVEEN ASSET MANAGEMENT, LLC (26.5K shares), CITADEL ADVISORS LLC (26.3K shares), and Assenagon Asset Management S.A. (17.3K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.